Planned intervention: On Wednesday April 3rd 05:30 UTC Zenodo will be unavailable for up to 2-10 minutes to perform a storage cluster upgrade.
Published May 31, 2018 | Version v1
Journal article Open

Preclinical evaluation of aerosol administration systems using Positron Emission Tomography

Description

Pulmonary administration of drugs has recently gained attention because it exhibits numerous advantages compared to oral or intravenous administration. The administration of aerosols for inhalation to animals, however, remains a critical challenge and only a few methods of administration have been developed. Herein, we compare the regional distribution of aerosols in the lungs of wild type rats after pulmonary administration using three different methods: (a) The Penn-Century MicroSprayer® Aerosolizer; (b) an in-house designed aerosol generation system; and (c) the Aeroneb® Lab Micropump Nebulizer. Both the regional distribution and the fraction of aerosol deposited in the lungs were determined by means of radiolabelling of the aerosol followed by in vivo and ex vivo Positron Emission Tomography (PET) imaging and dissection and gamma counting. Endotracheal nebulisation using the PennCentury MicroSprayer resulted in >85% of the administered dose accumulated in the lungs, with a non-uniform distribution of the radioactivity in different lobes and a low animal-to-animal reproducibility. Administration using the in-house designed and the Aeroneb nebulizers resulted in a uniform distribution over the lungs, but only a small fraction of the nebulized activity (ca. 0.1%) was deposited in the lungs.

Notes

This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 604434 (PneumoNP). This research was also supported by the Spanish Ministry of Economy and Competitiveness, project CTQ2017-87637-R. The authors would like to thank M. T. ten Kate (Erasmus MC, University Medical Center Rotterdam) for technical training regarding endotracheal insufflations.

Files

2018 European Journal of Pharmaceutics and biopharmaceutics.pdf

Files (1.1 MB)

Additional details

Funding

PNEUMONP – Nanotherapeutics to Treat Antibiotic Resistant Gram-Negative Pneumonia Infections 604434
European Commission